memantine derivatives (NeuroMolecular)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namememantine derivatives (NeuroMolecular)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsNitric oxide synthase inhibitors
TargetsGlutamate [NMDA] receptorNitric oxide synthase
Therapy Area/IndicationsNeuralgiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamas Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamas Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeuralgiaAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A